Atralin

Side Effects
Interactions

SIDE EFFECTS

Clinical Trials Experience

Because clinical trials are conducted under prescribing conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.

In two randomized, controlled trials, 674 subjects received treatment for up to 12 weeks with Atralin Gel [see Clinical Trials]. In these studies, 50% of the subjects who were treated with Atralin Gel reported one or more adverse reactions; 30% of the subjects reported treatment-related adverse reactions. In the vehicle group, 29% of the 487 randomized subjects reported at least one adverse reaction; 5% of the subjects reported events that were treatment-related. There were no serious, treatment-related adverse reactions reported by subjects in any of the treatment groups.

Selected adverse reactions that occurred in at least 1% of subjects in the two trials combined are shown in Table 1 (below). Most skin-related adverse reactions first appear during the first two weeks of treatment with Atralin Gel, and the incidence rate for skin-related reactions peaks around the second and third week of treatment. In some subjects the skin-related adverse reactions persists throughout the treatment period.

Table 1: Number of Subjects with Selected Adverse Reactions (Occurring in At Least 1% of Subjects)

Event Atralin Gel
(n = 674)
Vehicle Gel
(n = 487)
Dry Skin 109 (16%) 8 (2%)
Peeling/Scaling/ Flaking Skin 78 (12%) 7 (1%)
Skin Burning Sensation 53 (8%) 8 (2%)
Erythema 47 (7%) 1 ( < 1%)
Pruritus 11 (2%) 3 (1%)
Pain of Skin 7 (1%) 0 (0%)
Sunburn 7 (1%) 3 (1%)

Postmarketing Experience

The following adverse reactions have been identified during post-approval use of Atralin Gel. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Temporary hyper-or hypopigmentation has been reported with repeated application of tretinoin.

Read the Atralin (tretinoin) Side Effects Center for a complete guide to possible side effects

DRUG INTERACTIONS

No information provided.

Read the Atralin Drug Interactions Center for a complete guide to possible interactions

Last reviewed on RxList: 9/10/2014
This monograph has been modified to include the generic and brand name in many instances.

Side Effects
Interactions
A A A

Atralin - User Reviews

Atralin User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Atralin sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.


NIH talks about Ebola on WebMD